BabU
New member
Popular Antacid Ranitidine Likely To Go Off Essential Medicines’ List Due To Its Cancer-Causing Concerns Gliptins could be added in the list as they are the latest set of medicines used to treat type 2 diabetes. The sale of Gliptins in India is valued over Rs 4,000 crore annually out of which Teneligliptin market value is at Rs 1,000 crore